Skip to Main Content

Paper Details

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
Blood
269
2018
Author NameAffiliation
Peter WesterveltWashington University School of Medicine
John F DiPersioWashington University School of Medicine
Todd A FehnigerWashington University School of Medicine
  • 1 - 3

Datasets

Release 1.2